GlassScriptPhysician profile
Chirag K Patel
NPI 1376831990
$4,912.08
in general payments reported to CMS, 2019-2025
11 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $374 · 2021: $350 · 2022: $748 · 2023: $986 · 2024: $545 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,225 · Food and Beverage: $839 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $613 · Travel and Lodging: $42.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,225.00 |
| Food and Beverage | $839.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $612.50 |
| Travel and Lodging | $42.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,352.46 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,347.65 | 2019-2025 | Air Optix |
| Coopervision INC. | $1,235.24 | 2019-2025 | Clariti Contact Lens |
| Glaukos Corporation | $348.67 | 2022-2024 | Ce-Marked Kxla System |
| Tarsus Pharmaceuticals, INC. | $156.39 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $141.35 | 2023 | Miebo, Vyzulta |
| Dompe US, INC. | $127.92 | 2019-2025 | Oxervate |
| Oyster Point Pharma, INC. | $95.00 | 2023 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $44.94 | 2023 | Acthar |
| Harrow Eye, LLC | $38.24 | 2025 | |
| Sun Pharmaceutical Industries INC. | $24.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chirag Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.